Latest News
From Laboratory to Market: Risk Planning for Life Science Companies
The UK life sciences sector is entering an important phase of growth. The Government's Life Sciences Sector Plan sets an ambition for the UK to become the leading life sciences economy in Europe by 2030 and the third globally by 2035. It also reports that the sector...
Latest News
AI Governance in Biopharma Is Failing the Translation Test
Artificial intelligence is no longer experimental in biopharma. It is operational. Across drug discovery and development, AI systems are being used to identify targets, design molecules, optimize mRNA constructs, and simulate biological interactions that were...
Beyond Animal Models: iPSC Assays Unlock the Human Brain
For decades, neurodegenerative research has relied heavily on animal models. While transgenic mice and rats have yielded fundamental insights into the architecture of the central nervous system, they consistently hit a translational roadblock when applied to human...
AI Transparency Gap in SaMD Regulation
Artificial intelligence is no longer on the horizon of medical device regulation — it’s already on regulators’ desks. The FDA’s iterative guidance on AI/ML-based Software as a Medical Device (SaMD), the EU AI Act’s risk classification scheme, and Health Canada’s...
Merck’s $6.7bn Terns Deal: A New Oral CML Treatment
Merck has completed its $6.7 billion acquisition of Terns Pharmaceuticals, gaining control of TERN-701, an investigational oral CML treatment that the pharmaceutical giant hopes will become a cornerstone of its expanding cancer portfolio. The deal, which closed on 5...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Five Ways AI Will Reshape Life Sciences in 2026
Why People, Process, and Purpose Matter Most Following a period of experimentation, life sciences is entering a pivotal new phase in AI adoption. The industry is shifting away from hype-driven pilots and toward proven, value-led applications that improve how therapies...
Communication Breakdown: Why Soft Skills Are More Important Than Ever in Life Sciences
We all know or work with people who can be difficult to deal with and even talk to, and we all know or work with other people who are a joy to be around and who make the working day a little brighter. Some of those difficult people will be highly competent in their...
Why Hormone Tracking will be a Key Health Trend for 2026
Hormone health expert and bestselling author Dr Louise Newson explains why we'll all be tracking our hormones in 2026. The use of period tracking apps and menopause symptom tracker apps are at an all-time high. And it’s no wonder. These apps can be incredibly useful...
The Research Partnership That Looked Perfect – Until it Wasn’t
The dream is always the same: strike out on your own and build something that’s truly yours. Perhaps you’re spinning out from a university, commercialising years of research with a fellow academic who shares your vision. Or maybe you’re breaking away from the big...
Science & Nuclear Leaders Urge Pause on Apprenticeship Reforms
Leaders in life sciences and nuclear urge review of proposed changes Leaders across the science sector have made an urgent call to government to reconsider potentially harmful reforms to the way apprenticeships are assessed. Members of two leading employer bodies...
Basecamp Research Debuts World’s First AI for Programmable Gene Insertion
Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use. Trained in collaboration...
Metformin and Type 2 Diabetes: Benefits, Limitations and the Role of Diet
Metformin has been the first line drug treatment for type 2 diabetes for more than two decades and remains one of the most widely prescribed medicines globally. Its effectiveness, low cost and long safety record have made it a cornerstone of diabetes care. However, as...
OpenAI Accelerates Healthcare Strategy With ChatGPT Health
OpenAI is making its most coordinated move into healthcare to date, positioning ChatGPT Health as a central interface for clinical, research, and operational use across the medical ecosystem. Rather than launching a single consumer-facing medical product, the company...
Peptide and Biomolecule Research Bridges Consumer and Clinical Innovation
Peptides are no longer confined to the margins of biomedical research. Once viewed primarily as niche tools for probing biological pathways or as incremental drug candidates, peptides and related biomolecules are now emerging as a central pillar of innovation across...
The Lost World of Autism
Dhruv Shenai explores how females have been left behind in conversations on autism by discussing the history and lack of female representation within the field. Neuroscientist Gina Rippon has spent years challenging the male-centred bias in autism research. Her new...
FDA Novel Drug Approvals in 2025 Analysis and What it Signals for 2026
The U.S. Food and Drug Administration released its official list of novel drug approvals for 2025, marking a year of significant therapeutic breadth and scientific innovation. Novel drugs are defined as new molecular entities or biologics approved for use in the...
Why Life Sciences Can no Longer Rely on Traditional Media
The life sciences industry is advancing at a speed that would have felt unimaginable just a few years ago. Artificial intelligence is shortening drug discovery timelines. Digital therapeutics are reshaping care delivery. Precision medicine is moving healthcare from...
Five Ways AI Will Reshape Life Sciences in 2026
Why People, Process, and Purpose Matter Most Following a period of experimentation, life sciences is entering a pivotal new phase in AI adoption. The industry is shifting away from hype-driven pilots and toward proven, value-led applications that improve how therapies...
Communication Breakdown: Why Soft Skills Are More Important Than Ever in Life Sciences
We all know or work with people who can be difficult to deal with and even talk to, and we all know or work with other people who are a joy to be around and who make the working day a little brighter. Some of those difficult people will be highly competent in their...
Why Hormone Tracking will be a Key Health Trend for 2026
Hormone health expert and bestselling author Dr Louise Newson explains why we'll all be tracking our hormones in 2026. The use of period tracking apps and menopause symptom tracker apps are at an all-time high. And it’s no wonder. These apps can be incredibly useful...
The Research Partnership That Looked Perfect – Until it Wasn’t
The dream is always the same: strike out on your own and build something that’s truly yours. Perhaps you’re spinning out from a university, commercialising years of research with a fellow academic who shares your vision. Or maybe you’re breaking away from the big...
Science & Nuclear Leaders Urge Pause on Apprenticeship Reforms
Leaders in life sciences and nuclear urge review of proposed changes Leaders across the science sector have made an urgent call to government to reconsider potentially harmful reforms to the way apprenticeships are assessed. Members of two leading employer bodies...
Basecamp Research Debuts World’s First AI for Programmable Gene Insertion
Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use. Trained in collaboration...
Metformin and Type 2 Diabetes: Benefits, Limitations and the Role of Diet
Metformin has been the first line drug treatment for type 2 diabetes for more than two decades and remains one of the most widely prescribed medicines globally. Its effectiveness, low cost and long safety record have made it a cornerstone of diabetes care. However, as...
OpenAI Accelerates Healthcare Strategy With ChatGPT Health
OpenAI is making its most coordinated move into healthcare to date, positioning ChatGPT Health as a central interface for clinical, research, and operational use across the medical ecosystem. Rather than launching a single consumer-facing medical product, the company...
Peptide and Biomolecule Research Bridges Consumer and Clinical Innovation
Peptides are no longer confined to the margins of biomedical research. Once viewed primarily as niche tools for probing biological pathways or as incremental drug candidates, peptides and related biomolecules are now emerging as a central pillar of innovation across...
The Lost World of Autism
Dhruv Shenai explores how females have been left behind in conversations on autism by discussing the history and lack of female representation within the field. Neuroscientist Gina Rippon has spent years challenging the male-centred bias in autism research. Her new...
FDA Novel Drug Approvals in 2025 Analysis and What it Signals for 2026
The U.S. Food and Drug Administration released its official list of novel drug approvals for 2025, marking a year of significant therapeutic breadth and scientific innovation. Novel drugs are defined as new molecular entities or biologics approved for use in the...
Why Life Sciences Can no Longer Rely on Traditional Media
The life sciences industry is advancing at a speed that would have felt unimaginable just a few years ago. Artificial intelligence is shortening drug discovery timelines. Digital therapeutics are reshaping care delivery. Precision medicine is moving healthcare from...
Featured Articles
Further News
A New Year’s Resolution for 2026: Share Your Voice in Life Sciences
As 2026 begins, it is natural to pause and reflect on the year behind us while thinking about what lies ahead. In the life sciences, these reflections often centre on progress: new experiments to launch, collaborations to build, technologies to adopt, or ideas to...
Part III – China’s Biopharma Scale: Deals, Reimbursement and GLP-1s
Henry Li’s BioRoundup is a weekly analytical roundup that tracks where power, capital and science are actually moving in the global life-sciences ecosystem. Rather than simply reporting news headlines, Li curates developments from across deals, policy, industry...
Prostate Cancer Screening: What You Need to Know
Prostate cancer is one of the most common cancers affecting men worldwide. Across the UK, Europe and the United States, it remains a leading cause of cancer diagnosis in men and a significant contributor to cancer related mortality. Despite its prevalence, prostate...
Lego for Biotech Labs
How Modular Hardware Is Breaking Decades of Vendor Lock-In There’s a running joke among biotech lab managers that goes something like this: You don’t buy a bioreactor. You buy a relationship. A very expensive, very locked-in relationship. It’s funny because it’s...
J&J Axes Eczema Drug From $1.25B Acquisition
Johnson & Johnson has discontinued development of an eczema treatment that was a central asset in a biotechnology acquisition valued at up to 1.25 billion US dollars, following a recent internal portfolio review. The decision highlights the ongoing scientific and...
7,000 Steps a Day May Improve Brain and Reduce Disease Risk
Walking around 7,000 steps each day could help sharpen cognition and shield against a variety of chronic illnesses, according to a major new analysis. This target may be more attainable, yet still effective, than the widely publicised 10,000 step goal. Published in...
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Concerns are mounting that the United Kingdom’s official appraisal framework is systematically underestimating the economic and social value of investments in life sciences manufacturing. Industry bodies and independent analysts warn that the methods used to evaluate...
The Boom in Life Sciences in India
India is emerging as one of the most dynamic life sciences markets in the world. Long recognised for its strength in pharmaceuticals and generics, the country is now experiencing a broader life sciences boom that spans biotechnology, vaccines, medical devices,...
Part II – Trade, Capital and the UK Life Sciences Strategy
Henry Li’s BioRoundup is a weekly analytical roundup that tracks where power, capital and science are actually moving in the global life-sciences ecosystem. Rather than simply reporting news headlines, Li curates developments from across deals, policy, industry...
Mapping a Single Neuron
This visualization from the Lichtman Lab and Google Connectomics captures one of the most detailed looks we’ve ever had at a single cortical neuron. What you’re seeing isn’t an artist’s rendering — it’s a true 3D reconstruction built from electron microscopy, stitched...
Windward Bio Strikes $700M Licensing Deal for Qyuns Immunology Bispecific
Swiss biotechnology company Windward Bio has entered into a significant licensing agreement with Chinese biotech Qyuns Therapeutics, securing rights outside China to a clinical stage immunology bispecific antibody known as WIN027, also referred to as QX027N. The...
Manufacturing and Supply Chain Resilience for Advanced Therapies
Manufacturing and supply chain resilience has moved to the forefront of strategic planning across the life sciences industry as advanced therapies place unprecedented strain on existing production models. Cell therapies, gene therapies, mRNA platforms and increasingly...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.